# Current state
The question resolves YES if Altria reports >54.5B domestic cigarette shipments for full-year 2026 (reported in early 2027). 2025 actuals are known (~61.8B sticks); 2026 data will not be available until ~Jan/Feb 2027. The Kalshi market currently prices YES at 93%, which appears dramatically misaligned with quantitative projections.
# Timeline of key events
- **2026-01 (confirmed):** Altria reports full-year 2025 results: domestic cigarette shipments ~61.8B sticks, down ~10% YoY (7.9% on reported basis per Altria IR; ~10% per 2FIRSTS).
- **2026-01 (confirmed):** Altria provides 2026 EPS guidance of $5.56–$5.72 (+2.5%–5.5%); no volume guidance given.
- **2025-Q3 (confirmed):** Q3 2025 shipment decline was 8.2% YoY (Altria IR).
- **2025-Q1 (confirmed):** Q1 2025 shipment decline was 13.7% YoY (Altria IR).
- **2024 full-year (confirmed):** Cigarette shipments ~61.9B sticks, down ~10.2% from 2023 (Altria IR press release 2025-01).
- **2023 full-year (confirmed):** Shipments ~68B sticks, down ~7.6% YoY (Altria IR 2024-01).
---
# Event
Will Altria Group Inc. report above 54.5 billion domestic cigarette shipments in full-year 2026?
# Outcomes to forecast
- **Yes** (>54.5B sticks in 2026)
- **No** (≤54.5B sticks in 2026)
# Kalshi market anchor
**Current YES price: 93%** | 7-day change: –2% | 30-day change: –2% | Avg daily volume: 1,471 contracts | Range last 7 days: 93–98%. ⚠️ This price is SEVERELY MISALIGNED with quantitative projections — the market appears to be pricing the wrong direction or misreading the bucket structure.
# Sub-question answers
1. **Altria domestic cigarette shipments 2023–2025?** — 2023: ~68B sticks (Altria IR); 2024: ~61.9B sticks (Altria IR); 2025: ~61.8B sticks reported by 2FIRSTS/Altria IR Jan 2026. Note: conflict between sources on 2025 — Altria IR states 7.9% reported decline from ~67B implied base, suggesting ~61.8B; code_execution uses 61.9B for 2024 (confirmed).
2. **Recent YoY decline rate?** — 2022: ~9.8%; 2023: ~7.6%; 2024: ~10.2%; 2025: ~7.9% (reported) to ~10% (adjusted). Recent 3-year mean ≈ –9.3% [code_execution].
3. **Altria 2026 guidance for volume?** — No explicit volume guidance provided; only EPS guidance ($5.56–$5.72) [Altria IR Jan 2026]. Pricing, not volume recovery, drives EPS growth.
4. **Projected 2026 volume vs. 54.5B threshold?** — Starting from ~61.8B in 2025, applying –9.3% CAGR yields ~50.9B; applying –7.3% full-history mean yields ~53.2B; linear regression yields ~50.5B. All methods project 2026 **below 54.5B** [code_execution]. Break-even rate needed: ≤–6.2% compound, historically unprecedented given structural acceleration.
5. **Factors that could accelerate or slow decline?** — Accelerants: illicit e-vapor growth (Altria explicitly flagged), macroeconomic pressure on consumers, nicotine pouch substitution. Decelerants: menthol ban reversal (regulatory tail risk), FDA enforcement on illicit vape, consumer trade-back from pouches. No near-term regulatory catalyst identified to slow decline to <6% [claude_news].
# Key facts (high-confidence, factual)
1. [Altria IR Jan 2026] 2025 full-year domestic cigarette shipments: ~61.8B sticks, down 7.9% reported.
2. [Altria IR Jan 2025] 2024 full-year shipments: ~61.9B sticks, down ~10.2%.
3. [Altria IR Jan 2024] 2023 full-year shipments: ~68B sticks, down ~7.6%.
4. [code_execution] Recent 3-year mean decline rate: –9.31% (σ ≈ 0.40%); all projection methods yield 2026 volume of ~50–53B sticks.
5. [code_execution] Monte Carlo using recent-rate distribution: P(>54.5B) ≈ ~0%; using full-history distribution: ~23%.
6. [Altria IR Jan 2026] 2026 EPS guidance $5.56–$5.72; no volume guidance given.
7. [2FIRSTS] Illicit e-vapor and macroeconomic pressure explicitly cited as structural headwinds.
# Cross-market signals
- **Kalshi (this market):** YES at 93% — appears to reflect a market error or misinterpretation of bucket direction.
- **Kalshi related:** No other directly comparable cigarette volume markets found.
- **Polymarket:** No data retrieved.
- **Sportsbook implied:** N/A.
# Analyst opinions and speculation
- [Motley Fool, Mar 2026] Flagged long-term volume decline as the "major risk" for Altria in 2026; no volume recovery anticipated.
- [claude_news synthesis] Consensus view: ~8–11% annual decline continues; 2026 likely ~55–57B (optimistic end) or ~50–53B (base/pessimistic).
- [code_execution] All three quantitative methods (recent rate, full-history, linear regression) converge below 54.5B.
# Directional lean per outcome
- **Yes (>54.5B):** Would require decline rate to slow dramatically to <6.2%/yr — no historical precedent post-2021; no regulatory catalyst identified; illicit e-vapor headwinds ongoing. Very weak support.
- **No (≤54.5B):** Supported by all three quantitative projection methods, recent 3-year trend of ~9–10% declines, structural headwinds (illicit vape, consumer pressure), and analyst commentary. Strong support.
# Gaps / unknowns
- Exact 2025 base (61.8B vs 61.9B) — minor but affects projections marginally.
- Potential FDA enforcement action on illicit e-vapor (could slow decline, but not modeled).
- Menthol ban or other regulatory shock (tail risk both ways).
- Methodology change in how Altria reports shipments.
# Calibration anchors
- **Kalshi current YES price: 93%** — PRIMARY ANCHOR, but strongly contradicted by fundamentals.
- **Quantitative base case:** ~5–10% probability of YES (code_execution Monte Carlo with full-history distribution gives ~23%, recent-rate gives ~0%; synthesized ~5–10%).
- **Precedent:** Altria has not exceeded a prior year's shipment volume in any year since at least 2010; the structural decline has never reversed.
- **Critical insight:** The Kalshi market at 93% YES appears to be mispriced — possibly traders are reading "Above 54.5B" as the likely *current* level (confusing 2025 actuals of ~61.8B with the 2026 question), or misreading bucket direction. The fundamental probability of YES is **~10–25%**, not 93%.